Brendan Teehan - Net Worth and Insider Trading
Brendan Teehan Net Worth
The estimated net worth of Brendan Teehan is at least $1 Million dollars as of 2025-07-04. Brendan Teehan is the EVP, COO, HEAD OF COMMERCIAL of ACADIA Pharmaceuticals Inc and owns about 62,105 shares of ACADIA Pharmaceuticals Inc (ACAD) stock worth over $1 Million. Details can be seen in Brendan Teehan's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Brendan Teehan has not made any transactions after 2024-11-19 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Brendan Teehan
Brendan Teehan Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Brendan Teehan owns 1 companies in total, including ACADIA Pharmaceuticals Inc (ACAD) .
Click here to see the complete history of Brendan Teehan’s form 4 insider trades.
Insider Ownership Summary of Brendan Teehan
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| ACAD | ACADIA Pharmaceuticals Inc | 2024-11-19 | EVP & COO & Head of Commercial |
Brendan Teehan Latest Holdings Summary
Brendan Teehan currently owns a total of 1 stock. Brendan Teehan owns 62,105 shares of ACADIA Pharmaceuticals Inc (ACAD) as of November 19, 2024, with a value of $1 Million.
Latest Holdings of Brendan Teehan
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ACAD | ACADIA Pharmaceuticals Inc | 2024-11-19 | 62,105 | 20.95 | 1,301,100 |
Holding Weightings of Brendan Teehan
Brendan Teehan Form 4 Trading Tracker
According to the SEC Form 4 filings, Brendan Teehan has made a total of 16 transactions in ACADIA Pharmaceuticals Inc (ACAD) over the past 5 years, including 0 buys and 16 sells. The most-recent trade in ACADIA Pharmaceuticals Inc is the sale of 10,329 shares on November 19, 2024, which brought Brendan Teehan around $173,630.
Insider Trading History of Brendan Teehan
- 1
Brendan Teehan Trading Performance
Brendan Teehan Ownership Network
Ownership Network List of Brendan Teehan
Ownership Network Relation of Brendan Teehan
Brendan Teehan Owned Company Details
What does ACADIA Pharmaceuticals Inc do?
Who are the key executives at ACADIA Pharmaceuticals Inc?
Brendan Teehan is the EVP & COO & Head of Commercial of ACADIA Pharmaceuticals Inc. Other key executives at ACADIA Pharmaceuticals Inc include Chief Financial Officer Mark C. Schneyer , Principal Accounting Officer James Kihara , and director & PRESIDENT AND CEO Stephen Davis .
ACADIA Pharmaceuticals Inc (ACAD) Insider Trades Summary
Over the past 18 months, Brendan Teehan made 7 insider transaction in ACADIA Pharmaceuticals Inc (ACAD) with a net sale of 32,403. Other recent insider transactions involving ACADIA Pharmaceuticals Inc (ACAD) include a net sale of 45,542 shares made by Mark C. Schneyer , a net sale of 15,588 shares made by James Kihara , and a net sale of 96,771 shares made by Stephen Davis .
In summary, during the past 3 months, insiders sold 29,007 shares of ACADIA Pharmaceuticals Inc (ACAD) in total and bought 0 shares, with a net sale of 29,007 shares. During the past 18 months, 210,259 shares of ACADIA Pharmaceuticals Inc (ACAD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 210,259 shares.
ACADIA Pharmaceuticals Inc (ACAD)'s detailed insider trading history can be found in Insider Trading Tracker table.
ACADIA Pharmaceuticals Inc Insider Transactions
Brendan Teehan Mailing Address
Above is the net worth, insider trading, and ownership report for Brendan Teehan. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Brendan Teehan's mailing address is: San Diego Ca 92130.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
